1
|
Birsen R, Boutboul D, Crestani B, Seguin-Givelet A, Fieschi C, Bertinchamp R, Giol M, Malphettes M, Oksenhendler E, Galicier L. Talc pleurodesis allows long-term remission in HIV-unrelated Human Herpesvirus 8-associated primary effusion lymphoma. Leuk Lymphoma 2017; 58:1993-1998. [PMID: 28084853 DOI: 10.1080/10428194.2016.1271947] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Affiliation(s)
- Rudy Birsen
- a Department of Clinical Immunology , Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris (APHP) , Paris , France
| | - David Boutboul
- a Department of Clinical Immunology , Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris (APHP) , Paris , France.,b Inserm U1126, Centre Hayem, Hôpital Saint-Louis , Paris , France
| | - Bruno Crestani
- c Inserm U1152 , Université Paris Diderot Paris 7 , Paris , France.,d Department of Pneumology , Hôpital Bichat, Assistance Publique Hôpitaux de Paris (APHP) , Paris , France
| | - Agathe Seguin-Givelet
- e Department of Thoracic and Vascular Surgery , Hôpital Avicenne, Assistance Publique Hôpitaux de Paris (APHP) , Paris , France.,f Faculté de médecine SMBH , Université Sorbonne Paris Cité, Université Paris 13 , Bobigny , France
| | - Claire Fieschi
- a Department of Clinical Immunology , Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris (APHP) , Paris , France.,b Inserm U1126, Centre Hayem, Hôpital Saint-Louis , Paris , France.,g EA3518, Université Paris Diderot Paris 7 , Paris , France
| | - Remi Bertinchamp
- a Department of Clinical Immunology , Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris (APHP) , Paris , France
| | - Mihaela Giol
- h Department of Thoracic Surgery , Hôpital Tenon, Assistance Publique Hôpitaux de Paris (APHP) , Paris , France
| | - Marion Malphettes
- a Department of Clinical Immunology , Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris (APHP) , Paris , France.,b Inserm U1126, Centre Hayem, Hôpital Saint-Louis , Paris , France
| | - Eric Oksenhendler
- a Department of Clinical Immunology , Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris (APHP) , Paris , France.,g EA3518, Université Paris Diderot Paris 7 , Paris , France
| | - Lionel Galicier
- a Department of Clinical Immunology , Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris (APHP) , Paris , France.,g EA3518, Université Paris Diderot Paris 7 , Paris , France
| |
Collapse
|
2
|
Christenson ES, Teply B, Agrawal V, Illei P, Gurakar A, Kanakry JA. Human Herpesvirus 8-Related Primary Effusion Lymphoma After Liver Transplantation. Am J Transplant 2015; 15:2762-6. [PMID: 25988353 DOI: 10.1111/ajt.13321] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2015] [Revised: 03/17/2015] [Accepted: 03/18/2015] [Indexed: 01/25/2023]
Abstract
Primary effusion lymphoma is a rare subclass of non-Hodgkin lymphoma associated with human herpesvirus 8 infection and principally seen in human immunodeficiency virus-positive patients. We report on the case of a 72-year-old human immunodeficiency virus-negative male with a hepatic transplant 10 years prior, who presented with a symptomatic right-sided pleural effusion and was found to have primary effusion lymphoma by flow cytometric and cytopathologic examination. Immunohistochemistry of his lymphoma cells was positive for human herpesvirus 8. Both he and his donor had no identifiable risk factors for human herpesvirus 8 infection. The patient was intolerant of antiviral therapy and chemotherapy, dying 7 months after diagnosis. Posttransplant primary effusion lymphoma is exceedingly rare and carries a very poor prognosis. Individualized treatment strategies are necessary given the scant body of published literature with guidance based solely on case reports.
Collapse
Affiliation(s)
- E S Christenson
- Department of Medicine, Johns Hopkins University, Baltimore, MD
| | - B Teply
- Department of Oncology, Johns Hopkins University, Baltimore, MD
| | - V Agrawal
- Department of Medicine, Johns Hopkins University, Baltimore, MD
| | - P Illei
- Department of Pathology, Johns Hopkins University, Baltimore, MD
| | - A Gurakar
- Department of Medicine, Johns Hopkins University, Baltimore, MD
| | - J A Kanakry
- Department of Medicine, Johns Hopkins University, Baltimore, MD
| |
Collapse
|